Ftse Mib
34.339,32
0,55%
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
NASDAQ
16.346,26
0,27%
Bitcoin
62.668,94
-0,59%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ImmunoPrecise Antibodies Ltd (IPA) ImmunoPrecise Antibodies Ltd (IPA) Notizie

ImmunoPrecise Antibodies Ltd

IPA
1,26
-0,02 (-1,56%)
10 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/3/202419:35BWInterSystems et BioStrand, filiale d’IPA, collaborent au..
28/3/202412:02BWInterSystems and IPA’s Subsidiary BioStrand Collaborate to..
20/3/202418:52BWIPA acquiert l'instrument Carterra LSA® pour améliorer la..
20/3/202412:02BWIPA Acquires the Carterra LSA® Instrument to Enhance..
15/3/202400:39BWIPA présente ses résultats financiers et les récents points..
14/3/202413:05BWIPA Reports Financial Results and Recent Business Highlights..
07/3/202421:24BWBioStrand, filiale d'IPA, annonce une avancée majeure dans..
07/3/202417:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/3/202413:02BWIPA’s subsidiary BioStrand Unveils Major Breakthrough in..
04/3/202422:50BWL'IPA publiera ses résultats financiers et les faits..
04/3/202414:01BWIPA to Report Financial Results and Recent Business..
23/2/202423:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/2/202423:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/2/202421:12EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
10/1/202419:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/1/202419:33EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/12/202321:08BWIPA présente ses résultats financiers et les récents points..
14/12/202314:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202314:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202314:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202314:01BWIPA Reports Financial Results and Recent Business Highlights..
09/12/202303:57BWIPA annonce la clôture d'une offre publique d'actions..
08/12/202323:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/12/202323:00BWIPA Announces Closing of $1.265 Million Public Offering of..
07/12/202322:53EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202323:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202313:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202313:00BWIPA annonce le prix des actions ordinaires de son émission..
06/12/202312:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202302:22BWIPA annonce une proposition d'offre publique d'actions..
05/12/202322:35BWIPA Announces Proposed Public Offering of Common Shares
05/12/202322:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/11/202319:09BWImmunoPrecise Antibodies Ltd annonce des nominations clés au..
27/11/202314:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/11/202314:01BWImmunoPrecise Antibodies Ltd. Announces Key Board and Board..
16/11/202323:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202320:09BWBioStrand® dévoile une approche révolutionnaire de la..
13/11/202314:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202314:32BWBioStrand® Unveils a Revolutionary Approach to Biological..
25/10/202318:12BWBioStrand, filiale de l'IPA, fait le point sur LENSai™
25/10/202314:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202314:01BWIPA’s Subsidiary, BioStrand, Provides an Update on LENSai™
23/10/202319:36BWIPA apporte une mise à jour sur sa stratégie de croissance..
23/10/202314:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/10/202314:01BWIPA Provides Update on Growth Strategy and Recent Share..
20/10/202320:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202317:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/9/202322:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/9/202318:34BWImmunoPrecise Antibodies annonce le remplacement de son..
19/9/202314:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 1,26 Min: 1,26 Max: 1,32
Chiusura: 1,28

La tua Cronologia

NASDAQ
IPA
ImmunoPrecise Antibodies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network